Search

everythinglearnresearchcommunity

for

Search:↓

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

A man developed a benign tumor at his COVID-19 vaccination site, which was successfully removed with surgery.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Nanoparticles effectively deliver water-insoluble drugs to hair follicles, stimulating hair growth without irritating the skin.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Drug companies were interested in advertising directly to consumers to make back their money, but most didn't think it would help and were concerned about negative effects.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.